 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
antibiotic catabolic process
|
1 term
|
 |
|
Biochemical function
|
hydrolase activity
|
4 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
276:31913-31918
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-beta-lactamase.
|
|
J.H.Toney,
G.G.Hammond,
P.M.Fitzgerald,
N.Sharma,
J.M.Balkovec,
G.P.Rouen,
S.H.Olson,
M.L.Hammond,
M.L.Greenlee,
Y.D.Gao.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
IMP-1 metallo-beta-lactamase (class B) is a plasmid-borne zinc metalloenzyme
that efficiently hydrolyzes beta-lactam antibiotics, including carbapenems,
rendering them ineffective. Because IMP-1 has been found in several clinically
important carbapenem-resistant pathogens, there is a need for inhibitors of this
enzyme that could protect broad spectrum antibiotics such as imipenem from
hydrolysis and thus extend their utility. We have identified a series of
2,3-(S,S)-disubstituted succinic acids that are potent inhibitors of IMP-1.
Determination of high resolution crystal structures and molecular modeling of
succinic acid inhibitor complexes with IMP-1 has allowed an understanding of the
potency, stereochemistry, and structure-activity relationships of these
inhibitors.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. Binding modes of compounds 2 (shown in cyan) and
3 (shown in red) docked into the IMP-1 active site complexed
with compound 1.
|
 |
Figure 4.
Fig. 4. Binding modes of compound 8 docked into the
active site of IMP-1 using the x-ray crystal structure of IMP-1
complexed with compound 1 (shown in cyan). The two most probable
conformations of the S-isomer of compound 8 are shown in red and
in yellow.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2001,
276,
31913-31918)
copyright 2001.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
P.Vella,
W.M.Hussein,
E.W.Leung,
D.Clayton,
D.L.Ollis,
N.Mitić,
G.Schenk,
and
R.P.McGeary
(2011).
The identification of new metallo-β-lactamase inhibitor leads from fragment-based screening.
|
| |
Bioorg Med Chem Lett, 21,
3282-3285.
|
 |
|
|
|
|
 |
C.Bebrone,
P.Lassaux,
L.Vercheval,
J.S.Sohier,
A.Jehaes,
E.Sauvage,
and
M.Galleni
(2010).
Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.
|
| |
Drugs, 70,
651-679.
|
 |
|
|
|
|
 |
P.Oelschlaeger,
N.Ai,
K.T.Duprez,
W.J.Welsh,
and
J.H.Toney
(2010).
Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?
|
| |
J Med Chem, 53,
3013-3027.
|
 |
|
|
|
|
 |
S.M.Drawz,
and
R.A.Bonomo
(2010).
Three decades of beta-lactamase inhibitors.
|
| |
Clin Microbiol Rev, 23,
160-201.
|
 |
|
|
|
|
 |
Y.Yamaguchi,
N.Takashio,
J.Wachino,
Y.Yamagata,
Y.Arakawa,
K.Matsuda,
and
H.Kurosaki
(2010).
Structure of metallo-beta-lactamase IND-7 from a Chryseobacterium indologenes clinical isolate at 1.65-A resolution.
|
| |
J Biochem, 147,
905-915.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Minond,
S.A.Saldanha,
P.Subramaniam,
M.Spaargaren,
T.Spicer,
J.R.Fotsing,
T.Weide,
V.V.Fokin,
K.B.Sharpless,
M.Galleni,
C.Bebrone,
P.Lassaux,
and
P.Hodder
(2009).
Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries.
|
| |
Bioorg Med Chem, 17,
5027-5037.
|
 |
|
|
|
|
 |
E.E.Chufán,
M.De,
B.A.Eipper,
R.E.Mains,
and
L.M.Amzel
(2009).
Amidation of bioactive peptides: the structure of the lyase domain of the amidating enzyme.
|
| |
Structure, 17,
965-973.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.A.Sanchez,
J.H.Toney,
J.D.Thomas,
and
J.M.Berger
(2009).
A sensitive coupled HPLC/electrospray mass spectrometry assay for SPM-1 metallo-beta-lactamase inhibitors.
|
| |
Assay Drug Dev Technol, 7,
170-179.
|
 |
|
|
|
|
 |
B.M.Liénard,
G.Garau,
L.Horsfall,
A.I.Karsisiotis,
C.Damblon,
P.Lassaux,
C.Papamicael,
G.C.Roberts,
M.Galleni,
O.Dideberg,
J.M.Frère,
and
C.J.Schofield
(2008).
Structural basis for the broad-spectrum inhibition of metallo-beta-lactamases by thiols.
|
| |
Org Biomol Chem, 6,
2282-2294.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Sharma,
Z.Hu,
M.W.Crowder,
and
B.Bennett
(2008).
Conformational changes in the metallo-beta-lactamase ImiS during the catalytic reaction: an EPR spectrokinetic study of Co(II)-spin label interactions.
|
| |
J Am Chem Soc, 130,
8215-8222.
|
 |
|
|
|
|
 |
F.Simona,
A.Magistrato,
D.M.Vera,
G.Garau,
A.J.Vila,
and
P.Carloni
(2007).
Protonation state and substrate binding to B2 metallo-beta-lactamase CphA from Aeromonas hydrofila.
|
| |
Proteins, 69,
595-605.
|
 |
|
|
|
|
 |
J.Spencer,
and
T.R.Walsh
(2006).
A new approach to the inhibition of metallo-beta-lactamases.
|
| |
Angew Chem Int Ed Engl, 45,
1022-1026.
|
 |
|
|
|
|
 |
N.Selevsek,
A.Tholey,
E.Heinzle,
B.M.Liénard,
N.J.Oldham,
C.J.Schofield,
U.Heinz,
H.W.Adolph,
and
J.M.Frère
(2006).
Studies on ternary metallo-beta lactamase-inhibitor complexes using electrospray ionization mass spectrometry.
|
| |
J Am Soc Mass Spectrom, 17,
1000-1004.
|
 |
|
|
|
|
 |
J.Antony,
J.P.Piquemal,
and
N.Gresh
(2005).
Complexes of thiomandelate and captopril mercaptocarboxylate inhibitors to metallo-beta-lactamase by polarizable molecular mechanics. Validation on model binding sites by quantum chemistry.
|
| |
J Comput Chem, 26,
1131-1147.
|
 |
|
|
|
|
 |
J.G.Moloughney,
J.D Thomas,
and
J.H.Toney
(2005).
Novel IMP-1 metallo-beta-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1.
|
| |
FEMS Microbiol Lett, 243,
65-71.
|
 |
|
|
|
|
 |
M.H.Kim,
W.C.Choi,
H.O.Kang,
J.S.Lee,
B.S.Kang,
K.J.Kim,
Z.S.Derewenda,
T.K.Oh,
C.H.Lee,
and
J.K.Lee
(2005).
The molecular structure and catalytic mechanism of a quorum-quenching N-acyl-L-homoserine lactone hydrolase.
|
| |
Proc Natl Acad Sci U S A, 102,
17606-17611.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Sharma,
J.H.Toney,
and
P.M.Fitzgerald
(2005).
Expression, purification, crystallization and preliminary X-ray analysis of Aeromonas hydrophilia metallo-beta-lactamase.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 61,
180-182.
|
 |
|
|
|
|
 |
P.E.Tomatis,
R.M.Rasia,
L.Segovia,
and
A.J.Vila
(2005).
Mimicking natural evolution in metallo-beta-lactamases through second-shell ligand mutations.
|
| |
Proc Natl Acad Sci U S A, 102,
13761-13766.
|
 |
|
|
|
|
 |
T.R.Walsh,
M.A.Toleman,
L.Poirel,
and
P.Nordmann
(2005).
Metallo-beta-lactamases: the quiet before the storm?
|
| |
Clin Microbiol Rev, 18,
306-325.
|
 |
|
|
|
|
 |
M.Dal Peraro,
A.J.Vila,
and
P.Carloni
(2004).
Substrate binding to mononuclear metallo-beta-lactamase from Bacillus cereus.
|
| |
Proteins, 54,
412-423.
|
 |
|
|
|
|
 |
W.Jin,
Y.Arakawa,
H.Yasuzawa,
T.Taki,
R.Hashiguchi,
K.Mitsutani,
A.Shoga,
Y.Yamaguchi,
H.Kurosaki,
N.Shibata,
M.Ohta,
and
M.Goto
(2004).
Comparative study of the inhibition of metallo-beta-lactamases (IMP-1 and VIM-2) by thiol compounds that contain a hydrophobic group.
|
| |
Biol Pharm Bull, 27,
851-856.
|
 |
|
|
|
|
 |
C.Moali,
C.Anne,
J.Lamotte-Brasseur,
S.Groslambert,
B.Devreese,
J.Van Beeumen,
M.Galleni,
and
J.M.Frère
(2003).
Analysis of the importance of the metallo-beta-lactamase active site loop in substrate binding and catalysis.
|
| |
Chem Biol, 10,
319-329.
|
 |
|
|
|
|
 |
M.Goto,
H.Yasuzawa,
T.Higashi,
Y.Yamaguchi,
A.Kawanami,
S.Mifune,
H.Mori,
H.Nakayama,
K.Harada,
and
Y.Arakawa
(2003).
Dependence of hydrolysis of beta-lactams with a zinc(II)-beta-lactamase produced from Serratia marcescens (IMP-1) on pH and concentration of zinc(II) ion: dissociation of Zn(II) from IMP-1 in acidic medium.
|
| |
Biol Pharm Bull, 26,
589-594.
|
 |
|
|
|
|
 |
S.Siemann,
A.J.Clarke,
T.Viswanatha,
and
G.I.Dmitrienko
(2003).
Thiols as classical and slow-binding inhibitors of IMP-1 and other binuclear metallo-beta-lactamases.
|
| |
Biochemistry, 42,
1673-1683.
|
 |
|
|
|
|
 |
A.L.Carenbauer,
J.D.Garrity,
G.Periyannan,
R.B.Yates,
and
M.W.Crowder
(2002).
Probing substrate binding to metallo-beta-lactamase L1 from Stenotrophomonas maltophilia by using site-directed mutagenesis.
|
| |
BMC Biochem, 3,
4.
|
 |
|
|
|
|
 |
B.J.Denny,
P.A.Lambert,
and
P.W.West
(2002).
The flavonoid galangin inhibits the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia.
|
| |
FEMS Microbiol Lett, 208,
21-24.
|
 |
|
|
|
|
 |
D.Suárez,
N.Díaz,
and
K.M.Merz
(2002).
Molecular dynamics simulations of the dinuclear zinc-beta-lactamase from Bacteroides fragilis complexed with imipenem.
|
| |
J Comput Chem, 23,
1587-1600.
|
 |
|
|
|
|
 |
H.Mammeri,
S.Bellais,
and
P.Nordmann
(2002).
Chromosome-encoded beta-lactamases TUS-1 and MUS-1 from Myroides odoratus and Myroides odoratimimus (formerly Flavobacterium odoratum), new members of the lineage of molecular subclass B1 metalloenzymes.
|
| |
Antimicrob Agents Chemother, 46,
3561-3567.
|
 |
|
|
|
|
 |
S.Siemann,
D.P.Evanoff,
L.Marrone,
A.J.Clarke,
T.Viswanatha,
and
G.I.Dmitrienko
(2002).
N-arylsulfonyl hydrazones as inhibitors of IMP-1 metallo-beta-lactamase.
|
| |
Antimicrob Agents Chemother, 46,
2450-2457.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|